Bidirectional Inflammatory Mechanisms and Hematological/Coagulation Dysregulation in Psoriasis Complicated with Atherosclerosis: A Retrospective Hospital-Based Case-Control Study Leveraging the SH-YIMED Clinical Database

Psoriasis (Auckl). 2026 Jun 23;16:543978. doi: 10.2147/PTT.S543978. eCollection 2026.ABSTRACTBACKGROUND: Psoriasis is a chronic inflammatory skin disease associated with systemic inflammation, abnormal hemorheology, and coagulation dysfunction, all of which contribute to the development of atheroscl

M Miao Zhang

Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies

Target Oncol. 2026 Jun 29. doi: 10.1007/s11523-026-01230-3. Online ahead of print.ABSTRACTBACKGROUND: Abiraterone (ABI) and enzalutamide (ENZA) are standard treatments for metastatic castration-resistant prostate cancer (mCRPC). However, their safety and efficacy have not been directly compared in p

A Anikó Katalin Valikovics

Atopic Dermatitis: New Targets and Emerging Systemic Therapies

Am J Clin Dermatol. 2026 Jun 27. doi: 10.1007/s40257-026-01054-x. Online ahead of print.ABSTRACTAtopic dermatitis (AD) is a chronic inflammatory skin disease, driven by barrier and immune dysregulation, which causes significant impairment in quality of life. The introduction of biologics and oral sm

G Gianluca Avallone